Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria

Haematologica

Volumn 104, Issue 8, 2019, Pages 1682-1688

  Battipaglia, Giorgia ^a,b   Malard, Florent ^a,c   Rubio, Marie Therèse ^a,d,e   Ruggeri, Annalisa ^a   Mamez, Anne Claire ^a   Brissot, Eolia ^a,c   Giannotti, Federica ^a   Dulery, Remy ^a   Joly, Anne Christine ^a   Baylatry, Minh Tam ^a   Kossmann, Marie Jeanne ^a   Tankovic, Jacques ^a   Beaugerie, Laurent ^a   Sokol, Harry ^a,c,f   Mohty, Mohamad ^a,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SORBONNE UNIVERSITÉ   (France)

^d CHU NANCY BRABOIS   (France)

^e NANCY UNIVERSITÉ   (France)

^f UMR1319 MICALIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEPHALOSPORIN DERIVATIVE; ENEMA; IMMUNOSUPPRESSIVE AGENT; LAXATIVE; PIPERACILLIN PLUS TAZOBACTAM; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CASE REPORT; CITROBACTER FREUNDII; CLINICAL ARTICLE; COLITIS; CONSTIPATION; CYTOMEGALOVIRUS INFECTION; DIARRHEA; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEBRILE NEUTROPENIA; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NEUTROPHIL COUNT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; UNRELATED DONOR; VANCOMYCIN RESISTANT ENTEROCOCCUS; ALLOTRANSPLANTATION; COMPLICATION; DYSBIOSIS; HEMATOLOGIC DISEASE; MULTIDRUG RESISTANCE; PERIOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 85063427876     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2018.198549     Document Type: Article

References (30)

1. Spellberg B, Guidos R, Gilbert D, et al. The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155-164.
2. Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515-528.
3. Samet A, Śledzińska A, Krawczyk B, et al. Leukemia and risk of recurrent Escherichia coli bacteremia: Genotyping implicates E. Coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis. 2013;32(11):1393-1400.
4. Bilinski J, Robak K, Peric Z, et al. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study. Biol Blood Marrow Transplant. 2016; 22(6):1087-1093.
5. Cattaneo C, Zappasodi P, Mancini V, et al. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). Ann Hematol. 2016;95(12):1955-1963.
6. Birgand G, Leroy C, Nerome S, et al. Costs associated with implementation of a strict policy forcontrolling spread of highly resistant microorganisms in France. BMJ Open. 2016;6(1):1-9.
7. Lepelletier D, Berthelot P, Lucet J, et al. French recommendations for the prevention of “emerging extensively drug-resistant bacteria ” (eXDR). J Hosp Infect. 2015;90(3):186-195.
8. Bassetti M, Giacobbe DR, Giamarellou H, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018;24(2):133-144.
9. Tascini C, Sbrana F, Flammini S, et al. Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: Relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother. 2014; 58(4):1972-1976.
10. Lübbert C, Faucheux S, Becker-Rux D, et al. Rapid emergence of secondary resistance togentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: A single-centre experience. Int J Antimicrob Agents. 2013;42(6):565-570.
11. Rossen NG, MacDonald JK, De Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol. 2015;21(17):5359-5371.
12. Manges AR, Steiner TS, Wright AJ. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: A review. Infect Dis (Lond). 2016;48(8):587-592.
13. Stalenhoef JE, Terveer EM, Knetsch CW, et al. Fecal microbiota transfer for multidrug-resistant gram-negatives: A clinical success combined with microbiological failure. Open Forum Infect Dis. 2017;4(2):2-5.
14. Bilinski J, Grzesiowski P, Muszynski J, et al. Fecal microbiota transplantation inhibits multidrug-resistant gut pathogens: preliminary report performed in an immunocompromised host. Arch Immunol Ther Exp (Warsz). 2016;64(3):255-258.
15. de Castro CG Jr, Ganc AJ, Ganc RL, Petrolli MS, Hamerschlack N. Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant. 2014;50(1):145.
16. Kelly CR, Ihunnah C, Fischer M, et al. Fecal Microbiota Transplant for Treatment of Clostridium diffi cile Infection in Immunocompromised Patients. Am J Gastroenterol. 2014;109(7):1065-1071.
17. Bilinski J, Grzesiowski P, Sorensen N, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017; 65(3):364-370.
18. Magiorakos A, Srinivasan A, Carey RB, et al. bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011;18(3):268-281.
19. WHO. Antimicrobial resistance. Global Report on Surveillance. Bull World Health Organ. 2014;61(3):383-394.
20. Schaik W Van. The human gut resistome. Philos Trans R Soc Lond B Biol Sci. 2015;370(1670):20140087.
21. Taur Y, Jenq RR, Perales M, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2017;124 (7):1174-1183.
22. Jenq RR, Taur Y, Devlin SM, et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015;21(8):1373-1383.
23. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of clostridium difficile infections. Am J Med. 2014;127(6):479-483.
24. Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.Transpl Infect Dis. 2016;18(4): 628-633.
25. Defilipp Z, Peled JU, Li S, et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018;2(7):745-753.
26. Tang G, Yin W, Liu W. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis? Diagn Microbiol Infect Dis. 2017;88(4):322-329.
27. Moss EL, Falconer SB, Tkachenko E, et al. Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients. PLos One. 2017;12 (8):e0182585.
28. Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in 17 germfree mouse radiation chimeras. Radiat Res. 1971;45(3):577-588.
29. Shono Y, Docampo MD, Peled JU, et al. Increased GVHD-related mortality with broadspectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice Yusuke. Sci Transl Med. 2016;8(339):1-16.
30. Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood. 2016;128(16):2083-2088.